| View |
|
DRP-12192-01
|
Co-Amoxiclav
|
Asyclav
|
457 mg/5 mL
|
Powder For Oral Suspension
|
Antibacterial (Penicillin)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
02 February 2024
|
02 September 2027
|
| View |
|
DRP-12200-01
|
Rosuvastatin (as calcium)
|
Rosutech
|
20 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
14 February 2024
|
29 June 2027
|
| View |
|
DRP-12201-02
|
Rosuvastatin (as calcium)
|
Rosutech
|
10 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
14 February 2024
|
29 June 2027
|
| View |
|
DRP-12201-03
|
Rosuvastatin (as calcium)
|
Gorovast-10
|
10 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
14 February 2024
|
29 June 2027
|
| View |
|
DRP-12215-06
|
Acetylcysteine
|
Oxytech
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
12 February 2024
|
01 July 2027
|
| View |
|
DRP-12215-07
|
Acetylcysteine
|
Biolytic
|
600 mg
|
Effervescent Tablet
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 February 2024
|
01 July 2027
|
| View |
|
DRP-12239-06
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Montelog-L
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
21 February 2024
|
07 July 2027
|
| View |
|
DRP-12257-03
|
Fenofibrate
|
None
|
160 mg
|
Micronized Capsule
|
Lipid Modifying Agent (Fibrate)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
01 March 2024
|
05 July 2027
|
| View |
DRP-12142-01_PI_01.pdf
|
DRP-12142-01
|
Potassium Chloride
|
Poklor
|
750 mg
|
Extended-Release Tablet
|
Mineral
|
Globela Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
16 January 2024
|
20 June 2027
|
| View |
|
DRP-12291-02
|
Febuxostat
|
Febutor-80
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
20 February 2024
|
11 July 2027
|
| View |
|
DRP-12292-03
|
Febuxostat
|
Furinil
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
26 February 2024
|
12 July 2027
|
| View |
|
DRP-1233-02
|
Atorvastatin (as calcium)
|
Avamax
|
10 mg
|
Film-Coated Tablet
|
Antihypercholesterolemia
|
Ranbaxy (Malaysia) Sdn. Bhd
|
Malaysia
|
CLIDP Conversion
|
17 January 2024
|
02 February 2029
|
| View |
|
DRP-12388-01
|
Benzydamine Hydrochloride
|
Benzaclir
|
3 mg/mL (0.3% w/v)
|
Throat Spray (Mint Flavor)
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Interthai Pharmaceutical Manufacturing Ltd
|
Thailand
|
CLIDP Conversion
|
06 February 2024
|
29 July 2027
|
| View |
|
DRP-12389-01
|
Benzydamine (as Hydrochloride)
|
Benzaclir
|
3 mg / mL (0.3% w/v)
|
Throat Spray (Lemon Flavor)
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Interthai Pharmaceutical Manufacturing Ltd.
|
Thailand
|
CLIDP Conversion
|
15 February 2024
|
29 July 2027
|
| View |
|
DRP-12412-08
|
Losartan Potassium
|
Aceplor 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
16 January 2024
|
03 August 2025
|
| View |
|
DRP-12598-03
|
Palonosetron (as hydrochloride)
|
Palnostar
|
50 mcg/mL (250mcg/5mL)
|
Solution for Injection (IV)
|
Antiemetic/Antinauseant [Serotonin (5HT3) Anatagonist]
|
Sichuan Huiyu Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
14 February 2024
|
12 September 2027
|
| View |
|
DRP-12600-05
|
Febuxostat
|
None
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
15 February 2024
|
17 September 2027
|
| View |
|
DRP-12691-01
|
Vildagliptin
|
None
|
50 mg
|
Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 February 2024
|
22 September 2027
|
| View |
|
DRP-12735-04
|
Telmisartan + Amlodipine (as besilate)
|
Amity 80/10
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
19 January 2024
|
30 September 2027
|
| View |
|
DRP-12735-05
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 80/10
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
21 January 2024
|
30 September 2027
|